Loading stock data...

Sudarshan Pharma Industries Ltd.

BSE: SUDARSHAN

BSE
29.99 -0.61 (-1.99%)

Prev Close

30.6

Open Price

29.99

Volume

8,000

Today Low / High

29.99 / 29.99

52 WK Low / High

7.35 / 53.5

Range

28 - 31

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 29.99, reflecting a change of -0.61 (-1.99346%). The expected target range on the BSE is 28 - 31. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

13 Jun 29.99 0.00%
12 Jun 30.60 0.00%
11 Jun 31.22 0.00%
10 Jun 31.85 0.00%
09 Jun 31.27 3.90%
06 Jun 30.87 3.34%
05 Jun 30.38 3.69%
04 Jun 31.10 -0.32%
03 Jun 29.99 1.70%
02 Jun 28.82 4.02%
30 May 29.40 0.00%
29 May 29.99 0.00%
28 May 31.22 -1.99%
27 May 31.22 0.00%
26 May 31.85 0.00%
23 May 31.44 3.37%
22 May 30.86 3.95%
21 May 30.48 3.28%
20 May 30.56 1.60%
19 May 29.39 3.95%

Sudarshan Pharma Industries Ltd. Graph

Sudarshan Pharma Industries Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Sudarshan Pharma Industries Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 29.99, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 29.99 30.29 27.26 - 33.32
30.59 24.47 - 36.71
30.89 21.62 - 40.16
Bearish Scenario 29.99 29.69 26.72 - 32.66
29.39 23.51 - 35.27
29.09 20.36 - 37.82

Overview of Sudarshan Pharma Industries Ltd.

ISIN

INE00TV01015

Industry

Medical - Pharmaceuticals

Vol.Avg

181,627

Market Cap

7,217,359,511

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of SUDARSHAN

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2023-08-25 August 25, 23 0.03 0.3 2023-08-26 2023-10-02

Stock Rating Details for SUDARSHAN

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 505.05 Cr 446.87 Cr 58.18 Cr 0.1152 0.00 Cr 0.00 Cr 37.70 Cr 15.96 Cr 6.63 39.62 Cr 0.0316
2024-03-31 463.54 Cr 422.48 Cr 41.06 Cr 0.0886 0.00 Cr 0.00 Cr 21.57 Cr 11.46 Cr 4.76 25.42 Cr 0.0247
2023-03-31 461.33 Cr 442.06 Cr 19.28 Cr 0.0418 0.00 Cr 0.00 Cr 14.22 Cr 7.04 Cr 2.92 15.81 Cr 0.0153
2022-03-31 357.09 Cr 343.18 Cr 13.92 Cr 0.0390 0.00 Cr 0.81 Cr 10.15 Cr 5.25 Cr 2.20 10.93 Cr 0.0147
2021-03-31 193.35 Cr 181.42 Cr 11.93 Cr 0.0617 0.00 Cr 0.87 Cr 6.42 Cr 2.67 Cr 1.11 7.16 Cr 0.0138

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.55 Cr 402.41 Cr 270.93 Cr 131.4807 Cr 170.73 Cr 170.18 Cr 140.48 Cr 26.09 Cr 0.00 Cr 0.00 Cr 28.84 Cr 259.6934 Cr
2024-03-31 0.14 Cr 283.13 Cr 171.42 Cr 111.7067 Cr 104.84 Cr 104.69 Cr 85.74 Cr 22.41 Cr 2.55 Cr 0.00 Cr 12.34 Cr 160.8242 Cr
2023-03-31 17.80 Cr 232.51 Cr 131.53 Cr 100.9733 Cr 34.10 Cr 16.30 Cr 74.57 Cr 19.00 Cr 1.35 Cr 0.00 Cr 12.34 Cr 118.4768 Cr
2022-03-31 0.24 Cr 137.52 Cr 107.75 Cr 29.7753 Cr 30.59 Cr 30.36 Cr 46.87 Cr 6.88 Cr 0.00 Cr 0.00 Cr 0.00 Cr 102.6246 Cr
2021-03-31 2.39 Cr 99.26 Cr 76.70 Cr 22.5074 Cr 29.77 Cr 27.38 Cr 23.96 Cr 5.98 Cr 0.00 Cr 0.00 Cr 0.00 Cr 71.2217 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -45.4275 Cr -21.2078 Cr 67.0040 Cr -50.1739 Cr 0.0000 Cr 0.5505 Cr -4.7464 Cr 15.9552 Cr 65.8933 Cr 0.0000 Cr -54.7432 Cr
2024-03-31 -70.5440 Cr -6.2809 Cr 65.2485 Cr -74.3278 Cr -11.5750 Cr 0.1435 Cr -3.7839 Cr 15.2284 Cr -2.4313 Cr -0.7220 Cr -10.3975 Cr
2023-03-31 -29.3686 Cr -26.1422 Cr 66.9933 Cr -43.1715 Cr 13.3318 Cr 17.8046 Cr -13.8029 Cr 7.0367 Cr 3.5115 Cr 0.0000 Cr -27.6980 Cr
2022-03-31 -6.6203 Cr -1.7047 Cr 7.3061 Cr -8.2767 Cr -1.0189 Cr 0.2360 Cr -1.6564 Cr 5.2479 Cr 0.8214 Cr 0.0000 Cr -22.9057 Cr
2021-03-31 -7.9878 Cr -1.2709 Cr 9.2449 Cr -9.3077 Cr 0.9391 Cr 2.3877 Cr -1.3199 Cr 2.6712 Cr 1.2113 Cr 0.0000 Cr -6.5865 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2023-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 0.00 Cr 0.0000
2023-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 0.00 Cr 0.0000
2023-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 0.00 Cr 0.0000
2022-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 0.00 Cr 0.0000
2022-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 0.00 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-03-31 0.14 Cr 1.50 Cr 1.64 Cr 122.55 Cr 85.74 Cr 241.57 Cr 22.41 Cr 283.13 Cr 171.42 Cr
2023-09-30 8.57 Cr 0.00 Cr 8.57 Cr 0.00 Cr 78.26 Cr 227.94 Cr 20.89 Cr 265.05 Cr 158.96 Cr
2023-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2022-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2022-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2022-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 18.01 Cr 18.01 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2024-11-22 November 22, 24 10:1

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹880.60 ₹105,402,386,698.00 ₹101,481.00

Key Executives

Joint MD & Director
Mr. Sachin Vasantrai Mehta

Gender: male

Year Born: 1984

Independent Head of Pharma business in Manufacturing & Strategic Marketing
Mr. Vinay Kumar Singh

Gender: male

Year Born:

Chief Financial Officer
Mr. Manoj Lalchand Lodha CA

Gender: male

Year Born: 1968

Supply Chain Logistics Head
Ms. Geeta Ram Asare

Gender: female

Year Born:

Head of Sales & Marketing of Pharma Division
Mr. Indraraj Neogi

Gender: male

Year Born: 1980

Export Head
Mr. Shrinivas Patil

Gender: male

Year Born:

Company Secretary & Compliance Officer
Mr. Nirav Kishor Shah

Gender: male

Year Born:

Chairman & MD
Mr. Hemal Vasantrai Mehta

Gender: male

Year Born: 1977

Supply Chain Purchase Head
Mr. Bhavesh Kankia

Gender: male

Year Born:

Head of Sales & Marketing
Ms. Shrishti Mayekar

Gender: female

Year Born:

FAQs about Sudarshan Pharma Industries Ltd.

Who is the CEO of the company?

The CEO is Mr. Hemal Vasantrai Mehta.

What is the current market price of the stock?

The current price is ₹29.99.

What is the 52-week price range?

The range is ₹7.35-53.5.

What is the market capitalization of the company?

The market capitalization is ₹721.74 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 4.52.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Sudarshan Pharma Industries Ltd. (ISIN: INE00TV01015) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹721.74 crores and an average daily volume of 181,627 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack